The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
The Meals and Drug Administration (FDA) has accepted Libtayo (cemiplimab-rwlc) for the adjuvant, or postsurgical, remedy of adults with cutaneous squamous cell...
The U.S. Meals and Drug Administration (FDA) has granted quick monitor designation to UB-VV111 for the remedy of relapsed/refractory giant B-cell lymphoma...
